Category: Opioid Developments

24 posts found

Cebranopadol Phase 3 Trials Show Promising Results

A compound opioid/NOP receptor agonist demonstrated pain relief with a safety profile comparable to placebo.

NCCI hosted a recent webinar on opioid utilization, while Fair Health published a new Opioid Tracker tool to monitor state opioid data.

The AvertD test is intended to be used prior to first exposure to oral opioids in patients considered for a 4-30 day prescription for acute pain.

These funds will help states and communities respond more quickly, effectively, and equitably to prevent overdose death and injury.

RiVive will soon be available without a prescription for the treatment of known or suspected opioid overdose.

Opvee is a nalmefene hydrochloride nasal spray – a new option available for the reversal of opioid overdose.

Changes to boxed warnings, indications and usage, dosage and administration, and more.

This vaccine blocks fentanyl from entering the brain and triggering euphoric effect.

The public comment period is underway for this action, which could help with safer drug disposal.

Proposed changes are open to public comment until April 11th.

Alleged violations of the Controlled Substances Act could result in billions of dollars in penalties.

The drug manufacturer is pleading guilty and paying out billions.

With a flurry of opioid developments lately, what does the big picture look like?

The Society of Actuaries published a report that claims the economic burden of the opioid epidemic was $631 billion from 2015-2018.

An Oklahoma judge found the drug maker to be partially responsible for the harm of the opioid epidemic.

1 2 Next